Review of the firm’s manual log for SCARs (Supplier Corrective Action Requests) which was stated to betheoriginal, GMP document for tracicing these events found numerous entries for the past two years which were not closed out.
Inspection Record
Regeneron Pharmaceuticals, Inc. — FDA 483 Findings
View the regulator's official source The source document is always the basis for judgement.
Findings
There are no security measures employed in the issuance ofworksheets in the raw material testing laboratory located in building gay Inspection found that it is possible to print additiona) uncontrolled blank worksheets.
The role ofthe “reimbursement vendor” in providing information related to quality compiaints and the documentation in the complaint file of communications with that agent is not adequately addressed in the applicable complaint handling procedure.
A record as of the US FDA document published on 2024-01-17. Check the agency's announcements for any later corrective action, and rely on the original text. Translation and classification are machine-made.